Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
Damiano Paolicelli, Vita Direnzo, Maria TrojanoDepartment of Neurological and Psychiatric Sciences, University of Bari, Bari, ItalyAbstract: Multiple sclerosis (MS) is the most common autoimmune illness of the central nervous system. For many years the inflammatory manifestations of MS were treated...
Guardado en:
Autores principales: | Damiano Paolicelli, Vita Direnzo, Maria Trojano |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c29e7f5c1254fe1969becb677ec4d26 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
por: Slobodan M Jankovic
Publicado: (2010) -
Early stage and long term treatment of multiple sclerosis with interferon-β
por: Angela Applebee, et al.
Publicado: (2009) -
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
por: Castrop F, et al.
Publicado: (2013) -
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
por: Pietro Iaffaldano, et al.
Publicado: (2012) -
Natalizumab for the treatment of relapsing multiple sclerosis
por: Richard A Rudick, et al.
Publicado: (2008)